Category: Pharmaceuticals
Pharmaceuticals market research reports by Plunkett Research, Ltd.
-
Scientific Research and Development (R&D) in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2030, NAIC 541710
Scientific Research and Development (R&D) in Physics, Engineering, Life Sciences, Drugs, Telecommunications and Electronics Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 541710 Vital ... Read More
-
AmerisourceBergen Corporation (ABC:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
AmerisourceBergen Corporation (ABC:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry AmerisourceBergen Corporation (ABC:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industr ... Read More
-
McKesson Corporation (MCK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
McKesson Corporation (MCK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry McKesson Corporation (MCK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings: T ... Read More
-
Merck & Co Inc (MRK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Merck & Co Inc (MRK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Merck & Co Inc (MRK:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings: This unique n ... Read More
-
Johnson & Johnson (JNJ:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Johnson & Johnson (JNJ:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Johnson & Johnson (JNJ:NYS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry. Key Findings: This un ... Read More
-
Plunkett's Biotech, Pharmaceuticals & Genetics Industry Almanac 2024: Biotech, Pharmaceuticals & Genetics Industry Market Research, Statistics, Trends and Leading Companies
PLUNKETT'S BIOTECH, PHARMACEUTICALS & GENETICS INDUSTRY ALMANAC 2024 Key Findings: A complete market research report, including forecasts and market estimates, technologies analysis and developments at innovative firms within the Biotech, Pharmaceuticals & Genetics Industry. Gain vital insights tha ... Read More
-
Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2027, NAIC 541711
Scientific Research and Development (R&D) in Life Sciences, Medical Devices, Biotechnology and Pharmaceuticals (Drugs) Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 541711 Vital industry ... Read More
-
Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors (U.S.): Analytics, Extensive Financial Benchmarks, Metrics and Revenue Forecasts to 2027, NAIC 424200
Drugs (Pharmaceuticals) and Druggists' Merchandise Distributors Industry (U.S.): Analytics, Extensive Financial Metrics, Benchmarks Against Averages and Top Companies Within Its Industry, and Revenue Forecasts to 2030, NAIC 424200 Vital industry-specific data including metrics, benchmarks, historic ... Read More
-
Tarsus Pharmaceuticals Inc (TARS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Tarsus Pharmaceuticals Inc (TARS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Tarsus Pharmaceuticals Inc (TARS:NAS) compared to its top competitors and compar ... Read More
-
Timber Pharmaceuticals Inc (TMBR:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Timber Pharmaceuticals Inc (TMBR:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Timber Pharmaceuticals Inc (TMBR:ASE) compared to its top competitors and compar ... Read More
-
Acer Therapeutics Inc (ACER:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Acer Therapeutics Inc (ACER:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Acer Therapeutics Inc (ACER:NAS) compared to its top competitors and compared to the ... Read More
-
Navidea Biopharmaceuticals Inc (NAVB:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Navidea Biopharmaceuticals Inc (NAVB:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Navidea Biopharmaceuticals Inc (NAVB:ASE) compared to its top competitors an ... Read More
-
Syndax Pharmaceuticals (SNDX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Syndax Pharmaceuticals (SNDX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Syndax Pharmaceuticals (SNDX:NAS) compared to its top competitors and compared to th ... Read More
-
Apellis Pharmaceuticals (APLS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Apellis Pharmaceuticals (APLS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Apellis Pharmaceuticals (APLS:NAS) compared to its top competitors and compared to ... Read More
-
Rhythm Pharmaceuticals (RYTM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Rhythm Pharmaceuticals (RYTM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Rhythm Pharmaceuticals (RYTM:NAS) compared to its top competitors and compared to th ... Read More
-
Actinium Pharmaceuticals Inc (ATNM:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Actinium Pharmaceuticals Inc (ATNM:ASE): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Actinium Pharmaceuticals Inc (ATNM:ASE) compared to its top competitors and co ... Read More
-
Aerie Pharmaceuticals Inc (AERI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Aerie Pharmaceuticals Inc (AERI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Aerie Pharmaceuticals Inc (AERI:NAS) compared to its top competitors and compared ... Read More
-
Catalyst Pharmaceutical Inc (CPRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Catalyst Pharmaceutical Inc (CPRX:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Catalyst Pharmaceutical Inc (CPRX:NAS) compared to its top competitors and comp ... Read More
-
Ocuphire Pharma Inc (OCUP:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Ocuphire Pharma Inc (OCUP:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Ocuphire Pharma Inc (OCUP:NAS) compared to its top competitors and compared to the aver ... Read More
-
Mirum Pharmaceuticals Inc (MIRM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Mirum Pharmaceuticals Inc (MIRM:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Mirum Pharmaceuticals Inc (MIRM:NAS) compared to its top competitors and compared ... Read More
-
Verrica Pharmaceuticals Inc (VRCA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Verrica Pharmaceuticals Inc (VRCA:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Viridian Therapeutics Inc (VRDN:NAS) compared to its top competitors and compar ... Read More
-
CASI Pharmaceuticals Inc (CASI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
CASI Pharmaceuticals Inc (CASI:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for CASI Pharmaceuticals Inc (CASI:NAS) compared to its top competitors and compared t ... Read More
-
Deciphera Pharmaceuticals (DCPH:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Deciphera Pharmaceuticals (DCPH:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Deciphera Pharmaceuticals (DCPH:NAS) compared to its top competitors and compared ... Read More
-
Marinus Pharmaceuticals Inc (MRNS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Marinus Pharmaceuticals Inc (MRNS:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Marinus Pharmaceuticals Inc (MRNS:NAS) compared to its top competitors and comp ... Read More
-
Esperion Therapeutics Inc (ESPR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry
Esperion Therapeutics Inc (ESPR:NAS): Analytics, Extensive Financial Metrics, and Benchmarks Against Averages and Top Companies Within its Industry Key Findings: Unique new report provides deep financial benchmarks for Esperion Therapeutics Inc (ESPR:NAS) compared to its top competitors and compared ... Read More
Research Assistance
